PEGylated substance P augments therapeutic angiogenesis in diabetic critical limb ischemia

Hyun Ji Park, Suna Kim, Eun Je Jeon, In Taek Song, Haeshin Lee, Youngsook Son, Hyun Sook Hong, Seung Woo Cho

Research output: Contribution to journalArticlepeer-review

6 Citations (Scopus)


Substance P (SP) is a therapeutic peptide that has been widely used to induce angiogenesis and tissue regeneration. However, its therapeutic efficacy is often limited due to rapid degradation in vivo and a short half-life (˜1 min) after systemic administration. In the present study, we chemically modified SP with polyethylene glycol (PEG) to generate long-lasting formulations with increased stability and extended retention time in vivo and evaluated their ability to enhance therapeutic angiogenesis. Compared to the unmodified SP, PEGylated SP (PEG-SP) exhibited significantly increased half-life in vivo (˜360-fold increase in normal mouse and ˜120-fold increase in diabetic mouse). Systemic injection of PEG-SP led to a marked increase in therapeutic efficacy and angiogenesis in diabetic hindlimb ischemia, as evident from the remarkable improvement in salvage of ischemic limb and recovery of blood perfusion in diabetic mice with limb ischemia. These formulations increased endogenous stem cell mobilization to the injured site and modulated the immune system to increase microvessel formation and reduce systemic inflammation. Importantly, PEGylation efficiently reduced the injection doses of SP while still maintaining its therapeutic efficacy. To conclude, our study demonstrated that PEG-SP formulations exhibited an improved in vivo pharmacokinetic profile with enhanced efficacy and clinically acceptable treatment regimens, thus acting as a potent therapeutic for diabetic ischemia and inflammation.

Original languageEnglish
Pages (from-to)396-409
Number of pages14
JournalJournal of Industrial and Engineering Chemistry
Publication statusPublished - 2019 Oct 25

Bibliographical note

Funding Information:
The present work was supported by grants ( HI13C1479 and HI18C1492 ) from the Korea Health Technology R&D Project funded by the Ministry of Health and Welfare and a grant ( 2017R1A2B3005994 ) from the National Research Foundation of Korea (NRF) funded by the Ministry of Science and ICT (MSIT), Republic of Korea. We thank Prof. Byung-Soo Kim and Dr. Geunjae Jeong (School of Chemical and Biological Engineering, Seoul National University, Republic of Korea) for their help with Doppler imaging analysis.

Publisher Copyright:
© 2019 The Korean Society of Industrial and Engineering Chemistry

All Science Journal Classification (ASJC) codes

  • Chemical Engineering(all)


Dive into the research topics of 'PEGylated substance P augments therapeutic angiogenesis in diabetic critical limb ischemia'. Together they form a unique fingerprint.

Cite this